Post by Gilead Sciences on X
Gilead Sciences@GileadSciences
X#GileadNews: U.S. FDA approves our treatment for first-line metastatic triple-negative breast cancer, marking a new backbone therapy for people who previously had few options. Read more on this much-needed treatment option for the mTNBC community: t.co
14 likes1 repliesPosted Jun 24, 2026